H.R. 4342: Clarity for Opioid-Use Reduction and Expenditures Act
The bill, known as the Clarity for Opioid-Use Reduction and Expenditures Act (CURE Act), aims to amend the 21st Century Cures Act to enhance the administration, oversight, and effectiveness of grants aimed at addressing opioid use disorders. Below are the key changes proposed by the bill:
Standardized Data Collection
The Secretary of Health and Human Services will be required to create and implement a standardized system for collecting data from states that receive opioid use disorder grants. This system is meant to ensure consistency and reliability in the information gathered across different jurisdictions.
Grant Utilization Reporting
States that receive these grants will need to submit detailed information to the Secretary on a quarterly basis. This report must include:
- The specific purposes for which they spent the grant funds in the previous fiscal year.
- A description of activities conducted under the grant.
- The names, locations, and taxpayer identification numbers of any subrecipients who received grant funds.
- The total number of individuals served through the grant.
- Any other information deemed necessary by the Secretary.
Usage of Existing Grant-Tracking Systems
The Secretary will also be encouraged to utilize existing federal grant-tracking systems when collecting data to prevent duplication of efforts and improve efficiency.
Reports to Congress
The bill requires that reports submitted to Congress include detailed information about:
- The activities of grant recipients and subrecipients.
- The funding levels provided to each recipient or subrecipient of the grants.
Implementation Timeline
The amendments proposed by this bill will take effect 180 days after it is enacted into law.
Relevant Companies
None found.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
2 actions
Date | Action |
---|---|
Jul. 10, 2025 | Introduced in House |
Jul. 10, 2025 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.